WO2016086762A1 - 一种苄磺酰胺取代的丙烯酰胺衍生物 - Google Patents

一种苄磺酰胺取代的丙烯酰胺衍生物 Download PDF

Info

Publication number
WO2016086762A1
WO2016086762A1 PCT/CN2015/094556 CN2015094556W WO2016086762A1 WO 2016086762 A1 WO2016086762 A1 WO 2016086762A1 CN 2015094556 W CN2015094556 W CN 2015094556W WO 2016086762 A1 WO2016086762 A1 WO 2016086762A1
Authority
WO
WIPO (PCT)
Prior art keywords
substituted acrylamide
present
acrylamide derivative
benzylsulfamide
derivative
Prior art date
Application number
PCT/CN2015/094556
Other languages
English (en)
French (fr)
Inventor
刘扬
Original Assignee
青岛蓝帆新材料有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 青岛蓝帆新材料有限公司 filed Critical 青岛蓝帆新材料有限公司
Priority to EP15865915.1A priority Critical patent/EP3228614B1/en
Publication of WO2016086762A1 publication Critical patent/WO2016086762A1/zh

Links

Images

Classifications

    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004—Photosensitive materials
    • G03F7/027—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom

Definitions

  • the invention belongs to the field of chemical synthesis, and in particular relates to a benzylsulfonamide substituted acrylamide derivative.
  • Sulfonamides have a wide range of biological activities in sterilization, weeding, insecticidal, anti-cancer, anti-diabetes, etc., and therefore have attracted the attention of researchers in the fields of medicine and pesticides.
  • Unsaturated sulfonamide-substituted acrylamide compounds have a wide range of applications in the printing sector by homopolymerization or copolymers with other monomers bearing unsaturated double bonds.
  • Such a copolymer having a sulfonamide substituent as a primary or added binder for a lithographic printing plate can improve properties such as chemical resistance, abrasion resistance, development compatibility of a printing plate, and the like.
  • the introduction of an unsaturated double bond on the side chain imparts photopolymerizability, and can also be used for a negative PS plate, a CTP thermal plate, and a process-free thermal plate active composition.
  • the present invention provides a benzylsulfonamide substituted acrylamide derivative for use in a comonomer of a copolymer having a sulfonamide substituent.
  • the benzylsulfonamide substituted acrylamide derivative of the present invention has the structure of the following formula:
  • X represents an amino group or a fluorenyl group
  • R represents -H or -CH 3
  • R 1 represents a C 1 -C 4 alkyl group or an aryl group.
  • R 1 preferably represents -CH 3 .
  • the derivative of the present invention can be produced by a known method, for example, JP11-044956; USP20100298321; Tetrahedron Letters, 50(26), 3290-3293, 2009; Pharmaceutical Chemistry Journal, 46(7), 418-428; 2012 and so on.
  • the derivatives of the present invention are mainly produced by the following two methods:
  • R represents -H or -CH 3 and R 1 represents a C 1 -C 4 alkyl group or an aryl group.
  • X represents an amino group or a fluorenyl group
  • R represents -H or -CH 3
  • R 1 represents a C 1 -C 4 alkyl group or an aryl group.
  • the invention has the advantages that: (1) the traditional preparation route is adopted, the process parameters are not high, the preparation is simple, and only a suitable reactant is needed; (2) the yield is high, and the purification yield can reach 80% or more;
  • the derivative of the present invention is used as a monomer for synthesizing a copolymer having a sulfonamide substituent, and the synthesized copolymer can be used as a main or added binder for a lithographic printing plate to improve chemical resistance thereof. , wear resistance, development properties of the printing plate and other properties.
  • Figure 1 is a 1 H NMR spectrum of the compound prepared in Example 1;
  • Figure 2 is an IR spectrum of the compound prepared in Example 1;
  • Figure 3 is a 1 H NMR spectrum of the compound prepared in Example 2.
  • Figure 4 is an IR spectrum of the compound prepared in Example 2.
  • Figure 5 is a 1 H NMR spectrum of the compound prepared in Example 3.
  • Figure 6 is an IR spectrum of the compound prepared in Example 3.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明属于化学合成领域，具体涉及一种苄磺酰胺取代的丙烯酰胺衍生物，本发明的优点在于：(1)采用传统的制备路线，工艺参数要求不高，制备简单，只需要选取合适的反应物；(2)收率高，精制收率可达80％以上；(3)本发明所述的衍生物作为合成带有磺酰胺基取代基的共聚物的单体，合成的共聚物可以作为主要或添加的粘合剂用于平版印刷版，以提高其耐化学品性、耐磨性、印版的显影适性等性能。

Description

一种苄磺酰胺取代的丙烯酰胺衍生物 技术领域
本发明属于化学合成领域，具体涉及一种苄磺酰胺取代的丙烯酰胺衍生物。
背景技术
磺胺类化合物在杀菌、除草、杀虫、抗癌、抗糖尿病等方面具有广泛的生物活性，因此备受医药和农药领域研究者的关注。不饱和的带有磺酰胺基苯基取代的丙烯酰胺化合物通过均聚或者与其它带有不饱和双键的单体的共聚物在印刷版领域具有广泛的应用。这种带有磺酰胺基取代基的共聚物作为主要或添加的粘合剂用于平版印刷版，可以提高其耐化学品性、耐磨性、印版的显影适性等性能。其侧链上引入不饱和的双键赋予其光聚合性，还可以用于阴图PS版、CTP热敏版、免处理热敏版活性组合物。
发明内容
本发明的是提供一种苄磺酰胺取代的丙烯酰胺衍生物，用于带有磺酰胺基取代基的共聚物的共聚单体。
本发明所述的一种苄磺酰胺取代的丙烯酰胺衍生物，具有以下通式的结构：
Figure PCTCN2015094556-appb-000001
其中，X代表氨基或肼基，R代表-H或-CH3，R1代表C1～C4烷基或芳基。
其中，R1优选代表-CH3。
本发明所述的衍生物可以参照公知的方法制得，如：JP11-044956；USP20100298321；Tetrahedron Letters,50(26),3290-3293,2009；Pharmaceutical Chemistry Journal,46(7),418-428；2012等。
其中，本发明所述的衍生物主要通过以下两种方法制得：
第一种：
Figure PCTCN2015094556-appb-000002
其中，R代表-H或-CH3，R1代表C1～C4烷基或芳基。
第二种：
Figure PCTCN2015094556-appb-000003
其中，X代表氨基或肼基，R代表-H或-CH3，R1代表C1～C4烷基或芳基。
本发明的优点在于：(1)采用传统的制备路线，工艺参数要求不高，制备简单，只需要选取合适的反应物；(2)收率高，精制收率可达80％以上；(3)本发明所述的衍生物作为合成带有磺酰胺基取代基的共聚物的单体，合成的共聚物可以作为主要或添加的粘合剂用于平版印刷版，以提高其耐化学品性、耐磨性、印版的显影适性等性能。
附图说明
图1为实施例1所制得化合物的1H NMR图谱；
图2为实施例1所制得化合物的IR图谱；
图3为实施例2所制得化合物的1H NMR图谱；
图4为实施例2所制得化合物的IR图谱；
图5为实施例3所制得化合物的1H NMR图谱；
图6为实施例3所制得化合物的IR图谱。
具体实施方式
以下结合实施例和附图对本发明做进一步说明。
实施例1：
将甲基丙烯酸31.0g(0.36mol),氯甲酸乙酯39.1g(0.36mol)乙腈200ml加入到500毫升带有搅拌、温度计、和恒压滴液漏斗的三口烧瓶中，开动搅拌将混合物搅匀。用冰水浴冷却混合物，在1小时内滴加36.4g(0.36mol)三乙胺。滴加完毕后，撤去冰水浴，将滴液漏斗换成冷凝器。在室温继续搅拌30分钟。向反应混合物中加入1-(4-氨基苯基)-N-甲基-甲基磺酰胺60.08g(0.30mol),将混合物在70℃搅拌反应1小时。将反应混合物冷却后加到1升水中并搅拌30分钟。然后过滤，用500ml水打浆洗涤,干燥后得到30克白色粉末状的N-[4-((N-甲基-氨基磺酰)甲基)苯基]-2甲基-2-丙烯酰胺。HPLC(area％):95.81％,用乙腈重结晶得到的产品HPLC(area％)：99.09％，mp.189～190℃。
1H NMR(DMSO)(图1)δ：1.95(s,3H,-CH3),2.5～2.55(dd,3H,-CH3),4.27(s,2H,-CH2-),5.53(s,1H,-CH＝),5.81(s,1H,-CH＝),6.87～6.88(m,1H,-SO2-NH-),7.3～7.31(d,2H,ArH),7.67～7.69(d,2H,ArH)9.83(s,1H,-CO-NH)。
IR(图2)νcm-1：3312(N-H)，2973(-CH2-),2921(-CH2-)，2830(-CH2-)，1666(Ar-C＝O)，1627(N-H)，1599(CO-N)，1526(CO-N)，1413(C-N)，1324 (SO2-N)，1300(SO2-N)，1270(CO-NH)1159(SO2-N)，1116(S＝O),862(Ar-对位取代)。
实施例2：
将1-(4-氨基苯基)-N-甲基-甲基磺酰胺20.01g(0.1mol),丙酮100ml加入到250毫升带有搅拌、温度计、和恒压滴液漏斗的三口烧瓶中，开动搅拌将混合物搅匀。用冰盐浴冷却，在0-5℃下滴加丙烯酰氯9.05g(0.1mol),丙酮30ml的混合溶液。滴加完毕后再0℃继续反应2小时，撤去冰盐浴，自然升温室温下搅拌4小时。再升温倒40℃反应30分钟。降温到室温，向反应混合物中加入8.4g碳酸氢钠，100g水的溶液。pH6～7。过滤，水洗2次，干燥后得到19.03g准白色粉末。HPLC(area％)97.38％。用乙腈重结晶得到N-[4-((N-甲基-氨基磺酰)甲基)苯基]-2-丙烯酰胺，精制收率80.5％。外观准白色结晶，HPLC(area％)98.7％.mp.214～216.9℃。
1H NMR(DMSO)(图3)δ：2.49～2.54(dd,3H,-CH3),4.25(s,2H,-CH2-),5.74～5.76(s,1H,-CH＝),6.23～6.27(s,1H,-CH＝),6.4～6.45(s,1H,-CH＝),6.88～6.89(m,1H,-SO2-NH-),7.29～7.31(d,2H,ArH),7.64～7.65(d,2H,ArH)10.21(s,1H,-CO-NH)。
IR(图4)νcm-1：3297(N-H)，2972(-CH2-),2922(-CH2-)，1666(Ar-C＝O)，1636(N-H)，1605(CO-N)，1541(CO-N)，1416(C-N)，1333(SO2-N)，1311(SO2-N)，1272(CO-NH)1163(SO2-N)，1124(S＝O),856(Ar-对位取代)。
实施例3：
将1-(4-肼基苯基)-N-甲基-甲基磺酰胺12.59g(0.1mol),丙酮100ml加入到250毫升带有搅拌、温度计、和恒压滴液漏斗的三口烧瓶中，开动搅拌将混合物搅匀。用冰盐浴冷却。在0-5℃下滴加甲基丙烯酰氯5.23g(0.05mol),丙酮30ml 的混合溶液。滴加完毕后再0℃继续反应过夜，撤去冰盐浴，自然升温室温下搅拌48小时。向反应混合物中加入4.24g碳酸氢钠，250g水的溶液。pH6～7。过滤，水洗2次，干燥后得到1.91g准白色粉末。HPLC(area％)98.94％。得到N-[4-((N-甲基-氨基磺酰)甲基)苯基]-2-甲基丙烯酰肼mp.164.3～166.5℃。
1HNMR(DMSO)(图5)δ：1.89(s,3H,-CH3),2.49～2.52(dd,3H,-CH3),4.13(s,2H,-CH2-),5.43(s,1H,-CH＝),5.76(s,1H,-CH＝),6.82～6.84(m,1H,-SO2-NH-),6.67～6.70(d,2H,ArH),7.1～7.12(d,2H,ArH)，7.833～7.839(d,1H,Ar-NH-),9.859～9.864(d,1H,-CO-NH)。
IR(图6)νcm-1：3439(N-H)，3297(N-H)，3094(-CH2-),1651(Ar-C＝O)，1607(CO-N)，1514(CO-N)，1316(SO2-N)，1161(SO2-N)，1134(S＝O),838(Ar-对位取代)。

Claims (2)

  1. 一种苄磺酰胺取代的丙烯酰胺衍生物，其特征在于具有以下通式的结构：
    Figure PCTCN2015094556-appb-100001
    其中，X代表氨基或肼基，R代表-H或-CH3，R1代表C1～C4烷基或芳基。
  2. 根据权利要求1所述的一种苄磺酰胺取代的丙烯酰胺衍生物，其特征在于R1代表-CH3。
PCT/CN2015/094556 2014-12-03 2015-11-13 一种苄磺酰胺取代的丙烯酰胺衍生物 WO2016086762A1 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP15865915.1A EP3228614B1 (en) 2014-12-03 2015-11-13 Benzylsulfamide substituted acrylamide derivative

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201410728302.0A CN104402778B (zh) 2014-12-03 2014-12-03 一种苄磺酰胺取代的丙烯酰胺衍生物
CN201410728302.0 2014-12-03

Publications (1)

Publication Number Publication Date
WO2016086762A1 true WO2016086762A1 (zh) 2016-06-09

Family

ID=52640460

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2015/094556 WO2016086762A1 (zh) 2014-12-03 2015-11-13 一种苄磺酰胺取代的丙烯酰胺衍生物

Country Status (3)

Country Link
EP (1) EP3228614B1 (zh)
CN (1) CN104402778B (zh)
WO (1) WO2016086762A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104402778B (zh) * 2014-12-03 2017-04-05 青岛蓝帆新材料有限公司 一种苄磺酰胺取代的丙烯酰胺衍生物
CN104827795B (zh) * 2015-04-21 2018-03-06 青岛蓝帆新材料有限公司 一种阳图热敏平版印刷版版材
KR101615980B1 (ko) * 2015-07-22 2016-04-29 영창케미칼 주식회사 반도체 패턴 형성을 위한 KrF 레이저용 네가티브형 포토레지스트 조성물

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458855A (zh) * 2009-06-18 2012-05-16 爱克发印艺公司 平版印刷版前体
CN102504137A (zh) * 2011-11-11 2012-06-20 乐凯华光印刷科技有限公司 一种热塑性纳微米颗粒
CN104402778A (zh) * 2014-12-03 2015-03-11 山东本元功能材料有限公司 一种苄磺酰胺取代的丙烯酰胺衍生物
CN104503204A (zh) * 2014-12-15 2015-04-08 山东本元功能材料有限公司 一种阳图型PS版和CTcP平版印刷版版材

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2566162A (en) * 1950-08-18 1951-08-28 Eastman Kodak Co Acrylyl sulfanilamides and polymers thereof
JPS60185754A (ja) * 1984-03-05 1985-09-21 Mitsubishi Rayon Co Ltd メタクリル酸ヒドラジツド
PT2376480T (pt) * 2008-12-05 2016-10-26 Abbvie Inc Derivados de sulfonamida como agentes indutores de apoptose seletivos de bcl-2 para o tratamento do cancro e de doenças imunes
JP5240122B2 (ja) * 2009-08-21 2013-07-17 富士通モバイルコミュニケーションズ株式会社 移動無線端末および基地局探索方法
JP5193276B2 (ja) * 2010-12-10 2013-05-08 富士フイルム株式会社 レーザー彫刻用樹脂組成物、レーザー彫刻用レリーフ印刷版原版及びその製造方法、並びに、レリーフ印刷版の製版方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458855A (zh) * 2009-06-18 2012-05-16 爱克发印艺公司 平版印刷版前体
CN102504137A (zh) * 2011-11-11 2012-06-20 乐凯华光印刷科技有限公司 一种热塑性纳微米颗粒
CN104402778A (zh) * 2014-12-03 2015-03-11 山东本元功能材料有限公司 一种苄磺酰胺取代的丙烯酰胺衍生物
CN104503204A (zh) * 2014-12-15 2015-04-08 山东本元功能材料有限公司 一种阳图型PS版和CTcP平版印刷版版材

Also Published As

Publication number Publication date
EP3228614A1 (en) 2017-10-11
EP3228614B1 (en) 2020-11-11
CN104402778A (zh) 2015-03-11
EP3228614A4 (en) 2018-05-30
CN104402778B (zh) 2017-04-05

Similar Documents

Publication Publication Date Title
JP2022050538A (ja) プロスタサイクリン（ｐｇｉ２）受容体に関連する障害の処置に有用なｐｇｉ２受容体の調節因子
CA2652469C (fr) Derives de piperidine comme inhibiteurs du virus du papillome humain
JP2011515396A5 (zh)
WO2016086762A1 (zh) 一种苄磺酰胺取代的丙烯酰胺衍生物
JP2008526790A (ja) スクアリン酸誘導体
MXPA03001535A (es) Derivados de tiourea novedosos y las composiciones farmaceuticas que contienen los mismos.
SG182351A1 (en) Compounds and methods
WO2018019084A1 (zh) 一种苯甲酰胺类化合物及其在制备抑制癌细胞增殖和/或治疗癌症的药物中的应用
JP2017088632A (ja) ベンズアミド化合物の合成に有用な化合物
CN107646855B (zh) 一种含哌啶噻唑类化合物在制备杀菌剂中的应用及其制备方法
JP2010526045A (ja) Ｃｄｃ２５ホスファターゼインヒビターとしてのトリアミノピリミジン誘導体
US6914159B1 (en) Process for preparing sulfamoyl-substituted phenethylamine derivatives
CN1317265C (zh) 氰基丙烯酸酯衍生物及制备方法和生物活性
JPS606348B2 (ja) 新規ポリアミン類
US9951058B2 (en) Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient
JP2017523216A (ja) ダプソン及びその中間体を合成する方法
CN108026035B (zh) 具有蛋白酪氨酸磷酸酶shp-1激动剂活性的化合物
CN109232426A (zh) 一种n－羟基－5－取代－1h－吡唑－3－甲酰胺化合物及其制备方法和用途
TW201907918A (zh) 2-三氟甲基苯磺醯胺類衍生物的醫藥用途
WO2013111798A1 (ja) セリンラセマーゼ阻害剤
JP3752854B2 (ja) Ｎ−ベンジルカルバメイト化合物、その製法及び農園芸用の殺菌剤
WO1995010509A1 (fr) Derive de 4-imino-oxazolidin-2-one, procede pour produire ce compose et herbicide contenant ce compose comme principe actif
US20240124436A1 (en) Fluorine-containing pyrimidine compound and method for producing same
JP2003160546A5 (zh)
JPH0348905B2 (zh)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15865915

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2015865915

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2015865915

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE